Immunic IMUX 深 沪
交易中 10-06 10:14:07 美东时间
8.04
-0.030
-0.37%
华盛通- 最 高17.18
- 今 开8.13
- 成交量 3.93万股
- 最 低 7.70
- 昨 收 8.07
- 总市值 24.55万
- 52周最高 17.43
- 市盈率 静 --
- 换手率 128.82%
- 52周最低 0.8533
- 委 比 50.00%
- 总股本 3.05万
- 历史最高 289.90
- 量 比 1.23
- 振 幅 117.47%
- 历史最低 5.062
- 每 手 1
- 风险率 3.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience accelerates Immunic's Phase 3 trials in 2026.
05-27 18:17
Immunic Appoints Michael W. Bonney As Board Chairman
Mr. Bonney brings more than three decades of leadership experience in the biopharmaceutical industry, including significant expertise in multiple sclerosis (MS) and broader central nervous system markets. Notably, during
05-19 18:32
Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says
Stifel initiates coverage on Immunic (IMUX) with a Buy rating. Analysts see potential for VidoCa to disrupt the MS market via better safety.
04-18 02:20
D. Boral Capital Downgrades Immunic to Hold
D. Boral Capital analyst Jason Kolbert downgrades Immunic (NASDAQ:IMUX) from Buy to Hold.
04-15 20:24
Immunic Stock Jumps After Pricing $400 Million Private Placement
Immunic Inc (NASDAQ:IMUX) is surging Friday after the late‑stage biotech announced a private placement of up to $400 million.
02-14 00:25
EF Hutton Initiates Coverage On Immunic with Buy Rating, Announces Price Target of $17
EF Hutton analyst Jason Kolbert initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $17.
2024-09-16 20:25
B. Riley Securities Initiates Immunic at Buy With $6 Price Target
05:47 AM EDT, 08/27/2024 (MT Newswires) -- Immunic (IMUX) has an average outperform rating and a price target range of $5 to $28, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Eu...
2024-08-27 17:47
